North America Tumor Ablation Market Anticipated to Cross US$ 2.12 Billion by 2032, Reflecting 11.6% CAGR

𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚 𝐭𝐮𝐦𝐨𝐫 𝐚𝐛𝐥𝐚𝐭𝐢𝐨𝐧 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐢𝐳𝐞 𝐚𝐧𝐝 𝐬𝐡𝐚𝐫𝐞 𝐢𝐬 𝐜𝐮𝐫𝐫𝐞𝐧𝐭𝐥𝐲 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 𝐔𝐒𝐃 𝟎.𝟕𝟗 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟑 𝐚𝐧𝐝 𝐢𝐬 𝐚𝐧𝐭𝐢𝐜𝐢𝐩𝐚𝐭𝐞𝐝 𝐭𝐨 𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐞 𝐚𝐧 𝐞𝐬𝐭𝐢𝐦𝐚𝐭𝐞𝐝 𝐫𝐞𝐯𝐞𝐧𝐮𝐞 𝐨𝐟 𝐔𝐒𝐃 𝟐.𝟏𝟐 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟐, 𝐚𝐜𝐜𝐨𝐫𝐝𝐢𝐧𝐠 𝐭𝐨 𝐭𝐡𝐞 𝐥𝐚𝐭𝐞𝐬𝐭 𝐬𝐭𝐮𝐝𝐲 𝐛𝐲 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡. 𝐁𝐞𝐬𝐢𝐝𝐞𝐬, 𝐭𝐡𝐞 𝐫𝐞𝐩𝐨𝐫𝐭 𝐧𝐨𝐭𝐞𝐬 𝐭𝐡𝐚𝐭 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐞𝐱𝐡𝐢𝐛𝐢𝐭𝐬 𝐚 𝐫𝐨𝐛𝐮𝐬𝐭 𝟏𝟏.𝟔% 𝐂𝐨𝐦𝐩𝐨𝐮𝐧𝐝 𝐀𝐧𝐧𝐮𝐚𝐥 𝐆𝐫𝐨𝐰𝐭𝐡 𝐑𝐚𝐭𝐞 (𝐂𝐀𝐆𝐑) 𝐨𝐯𝐞𝐫 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭𝐞𝐝 𝐭𝐢𝐦𝐞𝐟𝐫𝐚𝐦𝐞, 𝟐𝟎𝟐𝟒 - 𝟐𝟎𝟑𝟐

The rising incidences of smoking and the growing prevalence of cancer are the primary factors driving the market demand for tumor ablation in North America. Besides, technological advancements in tumor ablation equipment that offer improved accuracy and mobility are other factors supporting the expansion of the market. Furthermore, the increasing incidences of cancer in several regions worldwide are likely to drive the market growth in North America.

𝐅𝐨𝐫 𝐌𝐨𝐫𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐨𝐧 𝐭𝐡𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭, 𝐆𝐞𝐭 𝐀 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.polarismarketresearch.com/industry-analysis/north-america-tumor-ablation-market/request-for-sample

𝐒𝐨𝐦𝐞 𝐎𝐟 𝐓𝐡𝐞 𝐌𝐚𝐣𝐨𝐫 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐈𝐧 𝐓𝐡𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐀𝐫𝐞:
• AngioDynamics Inc.
• Bioventus Inc.
• Boston Scientific Corp.
• EDAP TMS S.A.
• Galil Medical Inc.
• HealthTronics
• Medtronic Plc.
• Mermaid Medical
• Misonix, Inc.
• Neuwave Medical, Inc.
• SonaCare Medical

Tumor ablation is a minimally invasive procedure used in cancer treatment. It involves the use of extreme heat to destroy cancerous cells. Also, it's used for treating tumors of the kidney, lung, liver and pancreas. The procedure involves the insertion of a probe through the skin and into the tumor. To insert the probe, a computed tomography (CT) scan or ultrasound guidance.

After this, a heating source is used to heat the probe. Then the temperature of the probe is raised to around 100 degrees Celsius to heat and destroy the tumor. The procedure is typically performed when the tumor is hard to reach or located near important structures. Other instances when tumor ablation may be used in when the patient doesn't respond well to chemotherapy or the tumor has resurfaced after its surgical removal.

𝐆𝐞𝐭 𝐀𝐡𝐞𝐚𝐝 𝐰𝐢𝐭𝐡 𝐃𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬:
https://www.polarismarketresearch.com/buy/3725/2

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐥 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬

𝐁𝐲 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲
• Radiofrequency (RF) Ablation
• Microwave Ablation
• Cryoablation

𝐁𝐲 𝐌𝐨𝐝𝐞 𝐨𝐟 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭
• Surgical Ablation
• Laparoscopic Ablation
• Percutaneous Ablation

𝐁𝐲 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧
• Liver Cancer
• Lung Cancer
• Kidney Cancer
• Bone Metastasis

𝐆𝐫𝐨𝐰𝐭𝐡 𝐃𝐫𝐢𝐯𝐞𝐫𝐬:

𝐈𝐧𝐜𝐫𝐞𝐚𝐬𝐢𝐧𝐠 𝐂𝐚𝐧𝐜𝐞𝐫 𝐈𝐧𝐜𝐢𝐝𝐞𝐧𝐜𝐞: The rising prevalence of cancer in North America, including tumors in the liver, kidney, lung, and bone, drives the demand for tumor ablation procedures as part of comprehensive cancer care.

𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐦𝐞𝐧𝐭𝐬 𝐢𝐧 𝐀𝐛𝐥𝐚𝐭𝐢𝐨𝐧 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐞𝐬: Technological advancements in tumor ablation techniques, such as radiofrequency ablation (RFA), microwave ablation (MWA), cryoablation, and irreversible electroporation (IRE), have improved treatment outcomes and expanded the applicability of ablation procedures to a wider range of tumor types and sizes.

𝐒𝐡𝐢𝐟𝐭 𝐓𝐨𝐰𝐚𝐫𝐝𝐬 𝐌𝐢𝐧𝐢𝐦𝐚𝐥𝐥𝐲 𝐈𝐧𝐯𝐚𝐬𝐢𝐯𝐞 𝐓𝐡𝐞𝐫𝐚𝐩𝐢𝐞𝐬: Growing patient preference for minimally invasive treatments, which offer shorter recovery times, reduced hospital stays, and fewer complications compared to traditional surgery, fuels the adoption of tumor ablation procedures in North America.

𝐄𝐱𝐩𝐚𝐧𝐝𝐢𝐧𝐠 𝐆𝐞𝐫𝐢𝐚𝐭𝐫𝐢𝐜 𝐏𝐨𝐩𝐮𝐥𝐚𝐭𝐢𝐨𝐧: The aging population in North America, particularly the baby boomer generation, is more susceptible to cancer and may benefit from minimally invasive tumor ablation procedures as part of their cancer treatment journey.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐌𝐨𝐫𝐞 𝐃𝐞𝐭𝐚𝐢𝐥𝐬: https://www.polarismarketresearch.com/industry-analysis/north-america-tumor-ablation-market

𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚 𝐓𝐮𝐦𝐨𝐫 𝐀𝐛𝐥𝐚𝐭𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬

• The radiofrequency ablation segment held the largest market share in North America. It is extensively used in treating numerous types of cancer types, like kidney, lung, liver, and bone tumors.

• The percutaneous ablation segment held the highest market share in North America. Percutaneous ablation provides better security, fast recovery, and less scarring.

• Canada is anticipated to hold the fastest growth over the forecast period due to the increasing burden of cancer and the increasing cancer occurrence rate, which is 296.6 cases per 1,00,000 people every year.

𝐌𝐨𝐫𝐞 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐋𝐚𝐭𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

𝐑𝐞𝐦𝐨𝐭𝐞 𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐌𝐨𝐧𝐢𝐭𝐨𝐫𝐢𝐧𝐠 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.polarismarketresearch.com/industry-analysis/global-remote-patient-monitoring-devices-market

𝐌𝐮𝐥𝐭𝐢𝐩𝐥𝐞 𝐒𝐜𝐥𝐞𝐫𝐨𝐬𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.polarismarketresearch.com/industry-analysis/global-multiple-sclerosis-market

𝐋𝐢𝐪𝐮𝐢𝐝 𝐁𝐢𝐨𝐩𝐬𝐲 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.polarismarketresearch.com/industry-analysis/liquid-biopsy-market

𝐒𝐥𝐞𝐞𝐩 𝐀𝐩𝐧𝐞𝐚 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.polarismarketresearch.com/industry-analysis/sleep-apnea-devices-market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬:
Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.

This release was published on openPR.